(Allergan plc)

	AGN latest price $228.9465 (2.51%) ($224.9797 - $230.8479) on Thu. Oct. 23, 2014.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.6% (three month average)
RSI	40
Latest Price	$228.9465(2.51%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 1.3% a day on average for past five trading days.
Weekly Trend	AGN declines -2.7% a week on average for past two weeks.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(56%)    XBI(47%)    SPY(43%)    QQQ(42%)    VT(42%)
Factors Impacting AGN price	AGN will decline at least -0.8% in a week (0% probabilities).   VIXM(-32%)    TLT(-18%)    SHY(-8%)    IGOV(-5%)    GLD(-5%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.8% (StdDev 1.6%)
Hourly BBV	0 ()
Intraday Trend	1.5%

5 Day Moving Average	$222.4(2.94%)
10 Day Moving Average	$219.53(4.29%)
20 Day Moving Average	$226.45(1.1%)
To recent high	-4.4%
To recent low	17%
Market Cap	$75.484b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed